Insider Transactions in Q2 2018 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q2 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 05
2018
|
Giovanni Caforio Executive Chair of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
3,146
-1.08%
|
$160,446
$51.33 P/Share
|
|
May 05
2018
|
Giovanni Caforio Executive Chair of the Board |
SELL
Other acquisition or disposition
|
Direct |
1,643
-0.56%
|
-
|
|
May 05
2018
|
Giovanni Caforio Executive Chair of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
8,040
+2.67%
|
-
|
|
Apr 30
2018
|
Dinesh C Paliwal Director |
BUY
Open market or private purchase
|
Direct |
4,770
+37.28%
|
$248,040
$52.4 P/Share
|
|
Apr 03
2018
|
Thomas J. Lynch Jr. EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,088
-20.5%
|
$439,456
$62.77 P/Share
|
|
Apr 03
2018
|
Thomas J. Lynch Jr. EVP & Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
949
+4.71%
|
-
|
|
Apr 03
2018
|
Thomas J. Lynch Jr. EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,367
+26.89%
|
-
|